본문 바로가기

Data Plus(+)

All 807,818 Page 9,645/80,782

검색

Contents

No Journal_name Subject Date DOI Author
711378 JOURNAL FOR IMMUNOTHERAPY OF CANCER Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy 2021-07-01 10.1136/jitc-2020-001910 Cook Katherine W, Xue Wei, Symonds Peter, Daniels Ian, Gijon Mohamed, Boocock David, Coveney Clare, Miles Amanda K, Shah Sabaria, Atabani Suha, Choudhury Ruhul H, Vaghela Poonam, Weston Daisy, Metheringham Rachael L, Brentville Victoria A, Durrant Lindy G
711377 JOURNAL FOR IMMUNOTHERAPY OF CANCER Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors 2021-07-01 10.1136/jitc-2020-001587 Tenesaca Shirley, Vasquez Marcos, Alvarez Maite, Otano Itziar, Fernandez-Sendin Myriam, Di Trani Claudia Augusta, Ardaiz Nuria, Gomar Celia, Bella Angela, Aranda Fernando, Medina-Echeverz José, Melero Ignacio, Berraondo Pedro
711376 JOURNAL FOR IMMUNOTHERAPY OF CANCER Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors 2021-07-01 10.1136/jitc-2021-002851 Brown Jacqueline T, Liu Yuan, Shabto Julie M, Martini Dylan, Ravindranathan Deepak, Hitron Emilie Elise, Russler Greta Anne, Caulfield Sarah, Yantorni Lauren, Joshi Shreyas Subhash, Kissick Haydn, Ogan Kenneth, Nazha Bassel, Carthon Bradley C, Kucuk Omer, Harris Wayne B, Master Viraj A, Bilen Mehmet Asim
711375 JOURNAL FOR IMMUNOTHERAPY OF CANCER Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG m 2021-07-01 10.1136/jitc-2020-002267 Chu Yaya, Nayyar Gaurav, Jiang Susiyan, Rosenblum Jeremy M., Soon-Shiong Patrick, Safrit Jeffrey T, Lee Dean A., Cairo Mitchell S.
711374 JOURNAL FOR IMMUNOTHERAPY OF CANCER Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma 2021-07-01 10.1136/jitc-2020-002123 Mustafa Nurulhuda, Nee Adina Huey Fang, Chooi Jing Yuan, Toh Sabrina Hui Min, Chung Tae-Hoon, Selvarajan Viknesvaran, Fan Shuangyi, Ng Siok Bian, Poon Michelle, Chan Esther, Lee Joanne, Chee Yen Lin, Jeyasekharan Anand D, Zhou Longen, Yang Jennifer, Chng Wee Joo
711373 JOURNAL FOR IMMUNOTHERAPY OF CANCER STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation 2021-07-01 10.1136/jitc-2021-002852 Nakamura Takashi, Sato Takanori, Endo Rikito, Sasaki Shun, Takahashi Naomichi, Sato Yusuke, Hyodo Mamoru, Hayakawa Yoshihiro, Harashima Hideyoshi
711372 JOURNAL FOR IMMUNOTHERAPY OF CANCER Search for effective treatments in patients with advanced refractory melanoma continues: can novel intratumoral therapies deliver? 2021-07-01 10.1136/jitc-2021-002820 Najjar Yana G
711371 JOURNAL FOR IMMUNOTHERAPY OF CANCER Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers 2021-07-01 10.1136/jitc-2021-003044 Cunha Mateus Trinconi, Carvalho Vinicius Jardim, Loureiro Rafael Maffei, Brantis-de-Carvalho Carlos Eduardo, Cintra Murilo Bicudo, de Castro Junior Gilberto
711370 JOURNAL FOR IMMUNOTHERAPY OF CANCER First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer 2021-07-01 10.1136/jitc-2021-002926 Wang Shujing, Zhu Hua, Li Yingjie, Ding Jin, Wang Feng, Ding Lixin, Wang Xinyu, Zhao Jun, Zhang Yan, Yao Yunfeng, Zhou Tong, Li Nan, Wu Aiwen, Yang Zhi
711369 JOURNAL FOR IMMUNOTHERAPY OF CANCER Neutrophils in the era of immune checkpoint blockade 2021-07-01 10.1136/jitc-2020-002242 Faget Julien, Peters Solange, Quantin Xavier, Meylan Etienne, Bonnefoy Nathalie